Medicare Enrolled
Dr. Ryan Fogg, M.D.
Urology Physician · Gainesville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fogg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fogg?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fogg
Dr. Ryan Fogg is an urology physician in Gainesville, GA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Fogg performed 5,031 Medicare services across 3,062 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fogg received a total of $5,892 from 61 pharmaceutical and/or device companies across 295 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fogg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 20% volume in GA
$5,892 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,031
Medicare services
Top 20% in GA for urology physician
3,062
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~296 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,492 | $3 | $14 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
1,492 | $5 | $22 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
942 | $88 | $276 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
170 | $60 | $184 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
141 | $119 | $373 |
| New patient office visit, complex (60-74 min) | 132 | $156 | $550 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
121 | $111 | $453 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
102 | $18 | $72 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
69 | $38 | $109 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
51 | $63 | $272 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
49 | $61 | $366 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
40 | $97 | $463 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
35 | $10 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
30 | $120 | $450 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
25 | $125 | $578 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
24 | $325 | $821 |
| Injection of implant material into bladder or urethra A procedure where implant material is injected beneath the lining of the bladder and/or urethra using an endoscope. |
17 | $155 | $583 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
17 | $284 | $855 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
17 | $5 | $118 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
17 | $24 | $272 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
17 | $141 | $375 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
16 | $6 | $50 |
| Urethral dilation, female, subsequent A procedure to widen the urethra in a female patient during a follow-up visit. This is performed after an initial dilation has already taken place. |
15 | $48 | $199 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
2.7% medium
95.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,892
Total received (2018-2024)
Avg $842/year across 7 years
Top 37% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
295
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,721 (97.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$170 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$892
2023
$649
2022
$1,675
2021
$880
2020
$503
2019
$680
2018
$613
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$203
Axonics, Inc.
$158
ABBVIE INC.
$141
Sumitomo Pharma America, Inc.
$106
PROCEPT BioRobotics Corporation
$62
Dendreon Pharmaceuticals LLC
$38
Tempus AI, Inc
$29
Merck Sharp & Dohme LLC
$24
Astellas Pharma US Inc
$24
Bayer Healthcare Pharmaceuticals Inc.
$21
DENTSPLY IH AB
$19
Teleflex LLC
$17
PFIZER INC.
$17
Ferring Pharmaceuticals Inc.
$16
COLOPLAST CORP
$16
Top 3 companies account for 56.3% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$895
Boston Scientific Corporation
$691
ABBVIE INC.
$316
Accord Healthcare, Inc.
$252
Medtronic, Inc.
$249
PFIZER INC.
$236
Allergan, Inc.
$210
Rochester Medical Corporation
$193
Sumitomo Pharma America, Inc.
$192
Bayer HealthCare Pharmaceuticals Inc.
$181
Axonics, Inc.
$175
Blue Earth Diagnostics Limited
$148
COLOPLAST CORP
$140
Coloplast Corp
$130
Endo Pharmaceuticals Inc.
$118
TOLMAR Pharmaceuticals, Inc.
$108
Dendreon Pharmaceuticals LLC
$108
Myovant Sciences Inc.
$98
Allergan Inc.
$87
NeoTract Inc.
$81
AbbVie Inc.
$75
Amgen Inc.
$72
Teleflex LLC
$66
PROCEPT BioRobotics Corporation
$62
Janssen Biotech, Inc.
$61
180 Medical, Inc.
$56
ConvaTec Inc.
$49
Avadel Specialty Pharmaceuticals, LLC
$48
Laborie Medical Technologies Corp.
$44
Tolmar, Inc.
$42
Bayer Healthcare Pharmaceuticals Inc.
$41
Travere Therapeutics, Inc.
$37
UroGen Pharma, Inc.
$37
AbbVie, Inc.
$35
Retrophin, Inc.
$32
DENTSPLY IH Inc.
$32
UROVANT SCIENCES INC
$31
Merck Sharp & Dohme Corporation
$30
Photocure Inc
$30
C. R. Bard, Inc. & Subsidiaries
$29
Tempus AI, Inc
$29
BOSTON SCIENTIFIC CORPORATION
$27
Merck Sharp & Dohme LLC
$24
ACCORD HEALTHCARE, INC.
$21
AXOGEN
$20
KARL STORZ Endoscopy-America
$20
Myriad Genetic Laboratories, Inc.
$19
DENTSPLY IH AB
$19
Antares Pharma, Inc.
$18
Ambu Inc.
$18
AngioDynamics, Inc.
$17
TherapeuticsMD, Inc.
$16
AMAG Pharmaceuticals, Inc.
$16
Ferring Pharmaceuticals Inc.
$16
Mission Pharmacal Company
$15
Verity Pharmaceuticals Inc.
$15
Medtronic USA, Inc.
$13
MEDIVATION FIELD SOLUTIONS LLC
$13
AstraZeneca Pharmaceuticals LP
$13
Acerus Pharmaceuticals Corporation
$12
Olympus America Inc.
$11
Top 3 companies account for 32.3% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · AQUABEAM SYSTEM · AVANCE NERVE GRAFT · Androgel · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · Bulkamid · CAMCEVI · CYSVIEW · Cysview · EDEX · ELIGARD · Erleada · GEMTESA · GENTLECATH · GENTLECATH GLIDE · General - Kidney Stone Disease · IMVEXXY · INTERSTIM · INTRAROSA · Isiris aStent Removal Device · JATENZO · JELMYTO · KEYTRUDA · LITHOCLAST · LOFRIC · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NANOKNIFE · Natesto · Noctiva · Nubeqa · ORGOVYX · Olympus · PREMARIN · PROVENGE · Porges Coloplast · Prolaris · SPECTRA WAVEWRITER · Solyx SIS System · SpeediCath · TITAN · TOVIAZ · Thiola · Titan · Trelstar · UROLIFT · Uribel · UroLift · UroLift System · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
23
Per 100K population
11.0
County median income
$77,430
Nearest hospital
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fogg is a clinical cardiology specialist, with above-average Medicare volume (top 20% in GA), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fogg experienced with urinalysis with microscopic exam?
Based on Medicare claims data, Dr. Fogg performed 1,492 urinalysis with microscopic exam services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fogg receive payments from pharmaceutical companies?
Yes. Dr. Fogg received a total of $5,892 from 61 companies across 295 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fogg's costs compare to other urology physicians in Gainesville?
Dr. Fogg's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fogg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Gainesville
Browse urology physicians in Gainesville ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology